Editorial: Intranasal Drug Delivery: Challenges and Opportunities

被引：14
作者：
Fortuna, Ana [1 ,2 ]
Schindowski, Katharina [3 ]
Sonvico, Fabio [4 ,5 ]
机构：
[1] Univ Coimbra, Fac Pharm, Coimbra, Portugal
[2] Coimbra Inst Biomed Imaging & Translat Res CIBIT, Coimbra, Portugal
[3] Univ Appl Sci Biberach, Inst Appl Biotechnol, Biberach An Der Riss, Germany
[4] Univ Parma, Dept Food & Drug, Parma, Italy
[5] Univ Parma, Univ Res Ctr Innovat Hlth Prod, Biopharmanet TEC, Parma, Italy
来源：
FRONTIERS IN PHARMACOLOGY | 2022年 / 13卷
基金：
欧盟地平线“2020”;
关键词：
intranasal; nose to brain; systemic delivery; nasal epithelia; nasal formulations;
D O I：
10.3389/fphar.2022.868986
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：3
相关论文
共 12 条
[1]   Nasal nanovaccines [J].
Bernocchi, B. ;
Carpentier, R. ;
Betbeder, D. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 530 (1-2) :128-138
[2]   Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders [J].
Bicker, Joana ;
Fortuna, Ana ;
Alves, Gilberto ;
Falcao, Amilcar .
CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (05) :594-619
[3]   Chitosan in nasal delivery systems for therapeutic drugs [J].
Casettari, Luca ;
Illum, Lisbeth .
JOURNAL OF CONTROLLED RELEASE, 2014, 190 :189-200
[4]   Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs [J].
Clementino, Adryana Rocha ;
Pellegrini, Giulia ;
Banella, Sabrina ;
Colombo, Gaia ;
Cantu, Laura ;
Sonvico, Fabio ;
Del Favero, Elena .
MOLECULAR PHARMACEUTICS, 2021, 18 (08) :3132-3146
[5]   A consensus research agenda for optimising nasal drug delivery [J].
Forbes, Ben ;
Bommer, Rene ;
Goole, Jonathan ;
Hellfritzsch, Marie ;
De Kruijf, Wilbur ;
Lambert, Pierre ;
Caivano, Grazia ;
Regard, Alain ;
Schiaretti, Francesca ;
Trenkel, Marie ;
Vecellio, Laurent ;
Williams, Gerallt ;
Sonvico, Fabio ;
Scherliess, Regina .
EXPERT OPINION ON DRUG DELIVERY, 2020, 17 (02) :127-132
[6]   Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules [J].
Fortuna, Ana ;
Alves, Gilberto ;
Serralheiro, Ana ;
Sousa, Joana ;
Falcao, Amilcar .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 88 (01) :8-27
[7]   Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa [J].
Gaenger, Stella ;
Schindowski, Katharina .
PHARMACEUTICS, 2018, 10 (03)
[8]   Intranasal Antiviral Drug Delivery and Coronavirus Disease 2019 (COVID-19): A State of the Art Review [J].
Higgins, Thomas S. ;
Wu, Arthur W. ;
Illing, Elisa A. ;
Sokoloski, Kevin J. ;
Weaver, Bree A. ;
Anthony, Benjamin P. ;
Hughes, Nathan ;
Ting, Jonathan Y. .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2020, 163 (04) :682-694
[9]   Allogenic Fc Domain-Facilitated Uptake of IgG in Nasal Lamina Propria: Friend or Foe for Intranasal CNS Delivery? [J].
Ladel, Simone ;
Flamm, Johannes ;
Zadeh, Arghavan Soleimani ;
Filzwieser, Dorothea ;
Walter, Julia-Christina ;
Schlossbauer, Patrick ;
Kinscherf, Ralf ;
Lischka, Katharina ;
Luksch, Harald ;
Schindowski, Katharina .
PHARMACEUTICS, 2018, 10 (03)
[10]   Selective CNS Targeting and Distribution with a Refined Region-Specific Intranasal Delivery Technique via the Olfactory Mucosa [J].
Maigler, Frank ;
Ladel, Simone ;
Flamm, Johannes ;
Gaenger, Stella ;
Kurpiers, Barbara ;
Kiderlen, Stefanie ;
Voelk, Ronja ;
Hamp, Carmen ;
Hartung, Sunniva ;
Spiegel, Sebastian ;
Soleimanizadeh, Arghavan ;
Eberle, Katharina ;
Hermann, Rebecca ;
Krainer, Lukas ;
Pitzer, Claudia ;
Schindowski, Katharina .
PHARMACEUTICS, 2021, 13 (11)
12